Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950157-18-000022
Filing Date
2018-01-02
Accepted
2018-01-02 13:35:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 45080
  Complete submission text file 0000950157-18-000022.txt   46652
Mailing Address 575 MOUNTAIN AVENUE MURRAY HILL NJ 07974
Business Address 575 MOUNTAIN AVENUE MURRAY HILL NJ 07974 908-771-4757
Linde North America, Inc. (Filed by) CIK: 0001505451 (see all company filings)

EIN.: 201043281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88741 | Film No.: 18501088
SIC: 2834 Pharmaceutical Preparations